• Western blot testing of human Jurkat cell lysate with CIP2A antibody at 1:2000. Predicted molecular weight: ~102 kDa, routinely observed at ~90 kDa.
1 1

NSJ Bioreagents

F54179-0.05ML

CIP2A Antibody / p90 Autoantigen (Center Region)

CIP2A Antibody / p90 Autoantigen (Center Region)

Size

Cancerous Inhibitor of Protein Phosphatase 2A is an oncoprotein that inhibits PP2A and stabilizes MYC in human malignancies. Promotes anchorage-independent cell growth and tumor formation.

Specifications

Family Primary antibody
Formulation In 1X PBS, pH 7.4, with 0.09% sodium azide
Format Antigen affinity purified
Host Animal Rabbit
Clonality Polyclonal (rabbit origin)
Isotype Rabbit Ig
Species Reactivity Human
Application WB
Application Details Western blot: 1:1000-1:2000
Application Note The stated application concentrations are suggested starting points. Titration of the CIP2A antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Immunogen A portion of amino acids 537-567 from human KIAA1524 was used as the immunogen for the CIP2A antibody.
Purity Antigen affinity
Storage Aliquot the CIP2A antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This CIP2A antibody is available for research use only.
Uniprot # Q8TCG1
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/cip2a-antibody-p90-autoantigen-center-region-f54179
Title CIP2A Antibody / p90 Autoantigen (Center Region)
Description Cancerous Inhibitor of Protein Phosphatase 2A is an oncoprotein that inhibits PP2A and stabilizes MYC in human malignancies. Promotes anchorage-independent cell growth and tumor formation.
전체 세부 정보 보기